CoChat
Cited by 241

The DOI matches its Crossref record.

Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

Open access
Ungaro, Ryan C., Yzet, Clara, Bossuyt, Peter, Baert, Filip J., Vanasek, Thomas, D’Haens, Geert R., Joustra, Vincent Wilhelmus, Panaccione, Remo, Novacek, Gottfried, Reinisch, Walter, Armuzzi, Alessandro, Golovchenko, Oleksandr, Prymak, Olga, Goldis, Adrian, Travis, Simon P., Hébuterne, Xavier, Ferrante, Marc, Rogler, Gerhard, Fumery, Mathurin, Danese, Silvio, Rydzewska, Grazyna, Pariente, Benjamin, Hertervig, Erik, Stanciu, Carol, Serrero, Melanie, Diculescu, Mircea, Peyrin-Biroulet, Laurent, Laharie, David, Wright, John P., Gomollón, Fernando, Gubonina, Irina, Schreiber, Stefan, Motoya, Satoshi, Hellström, Per M., Halfvarson, Jonas, Butler, James W., Petersson, Joel, Petralia, Francesca, Colombel, Jean-Frederic · 2020 · Gastroenterology

Abstract

BACKGROUND & AIMS: We investigated the effects of inducing deep remission in patients with early Crohn’s disease (CD). METHODS: We collected follow-up data from 122 patients (mean age, 31.2 ± 11.3 y) with early, moderate to severe CD (median duration, 0.2 years; interquartile range, 0.1–0.5) who participated in the Effect of Tight Control Management on CD (CALM) study, at 31 sites, representing 50% of the original CALM patient population. Fifty percent of patients (n = 61) were randomly assigned to a tight control strategy (increased therapy based on fecal level of calprotectin, serum level of C-reactive protein, and symptoms), and 50% were assigned to conventional management. We categorized patients as those who were vs were not in deep remission (CD endoscopic index of severity scores below 4, with no deep ulcerations or steroid treatment, for 8 or more weeks) at the end of the follow-up period (median, 3.02 years; range, 0.05–6.26 years). The primary outcome was a composite of major adverse outcomes that indicate CD progression during the follow-up period: new internal fistulas or abscesses, strictures, perianal fistulas or abscesses, or hospitalization or surgery for CD. Kaplan-Meier and penalized Cox regression with bootstrapping were used to compare composite rates between patients who achieved or did not achieve remission at the end of the follow-up period. RESULTS: Major adverse outcomes were reported for 34 patients (27.9%) during the follow-up period. Significantly fewer patients in deep remission at the end of the CALM study had major adverse outcomes during the follow-up period (P = .01). When we adjusted for potential confounders, deep remission (adjusted hazard ratio, 0.19; 95% confidence interval, 0.07–0.31) was significantly associated with a lower risk of major adverse outcome. CONCLUSIONS: In an analysis of follow-up data from the CALM study, we associated induction of deep remission in early, moderate to severe CD with decreased risk of disease progression over a median time of 3 years, regardless of tight control or conventional management strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2020.03.039

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 241

Metadata

Authors
Ungaro, R. C., Yzet, C., Bossuyt, P., Baert, F. J., Vanasek, T., D’Haens, G. R., Joustra, V. W., Panaccione, R., Novacek, G., Reinisch, W., Armuzzi, A., Golovchenko, O., Prymak, O., Goldis, A., Travis, S. P., Hébuterne, X., Ferrante, M., Rogler, G., Fumery, M., Danese, S., Rydzewska, G., Pariente, B., Hertervig, E., Stanciu, C., Serrero, M., Diculescu, M., Peyrin-Biroulet, L., Laharie, D., Wright, J. P., Gomollón, F., Gubonina, I., Schreiber, S., Motoya, S., Hellström, P. M., Halfvarson, J., Butler, J. W., Petersson, J., Petralia, F., & Colombel, J.-F.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2020-07
Volume
159
Issue
1
Pages
139-147
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3013062810
Cited by
241
References
0
FWCI
16.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease. https://app.cochat.ai/papers/10.1053/j.gastro.2020.03.039
The paper
Ungaro, R. C., Yzet, C., Bossuyt, P., Baert, F. J., Vanasek, T., D’Haens, G. R., Joustra, V. W., Panaccione, R., Novacek, G., Reinisch, W., Armuzzi, A., Golovchenko, O., Prymak, O., Goldis, A., Travis, S. P., Hébuterne, X., Ferrante, M., Rogler, G., Fumery, M., . . . Colombel, J.-F. (2020). Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.03.039

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.